Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Diabetes. Dec 15, 2013; 4(6): 295-302
Published online Dec 15, 2013. doi: 10.4239/wjd.v4.i6.295
Published online Dec 15, 2013. doi: 10.4239/wjd.v4.i6.295
Clinical trials on corticosteroids for diabetic macular edema
Hassan A Al Dhibi, J Fernando Arevalo, Vitreoretinal Division, King Khaled Eye Specialist Hospital, Riyadh 11462, Saudi Arabia
J Fernando Arevalo, Retina Division, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, United States
Author contributions: Al Dhibi HA and Arevalo JF were both equally involved in writing and editing the manuscript.
Correspondence to: Hassan A Al Dhibi, MD, Vitreoretinal Division, King Khaled Eye Specialist Hospital, Al-Oruba Street, PO Box 7191, Riyadh 11462, Saudi Arabia. hdhibi@kkesh.med.sa
Telephone: +966-1-4821234 Fax: +966-1- 4821234-3727
Received: December 27, 2012
Revised: July 17, 2013
Accepted: August 4, 2013
Published online: December 15, 2013
Processing time: 147 Days and 2.8 Hours
Revised: July 17, 2013
Accepted: August 4, 2013
Published online: December 15, 2013
Processing time: 147 Days and 2.8 Hours
Core Tip
Core tip: Despite the documented ocular side effects of corticosteroids by the time being they are still considered as one of the essential effective adjunct modalities for the treatment of diabetic macular edema especially in refractory and persistent cases.